Shanghai, China

Miao Dai

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 11.6

ph-index = 5

Forward Citations = 68(Granted Patents)


Location History:

  • Dover, MA (US) (2011)
  • Shanghai, CA (US) (2013)
  • Shanghai, CN (2013)

Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Innovations by Inventor Miao Dai in Cancer Treatment

Introduction

Miao Dai is an accomplished inventor based in Shanghai, China, known for his significant contributions to the field of medicinal chemistry. With a commendable portfolio of seven patents, he focuses primarily on developing compounds that have potential uses in treating proliferative diseases, particularly cancer. His innovative approach has made him a valued figure in the pharmaceutical industry.

Latest Patents

Among his latest inventions, Miao Dai's patents include groundbreaking compounds aimed at improving cancer treatment. One notable patent features the compound (S)-N-((S)-1-cyclohexyl-2-{(S)-2-[4-4-(4-fluorobenzoyl)-thiazol-2-yl]pyrrolidin-1-yl}-2-oxoethyl)-2-methylamino-propionamide, which offers a promising pathway for treating proliferative diseases in mammals. Furthermore, he has developed SMAC peptidomimetics which serve as IAP inhibitors, presenting an innovative avenue for addressing cancer challenges.

Career Highlights

Miao Dai is affiliated with Novartis AG, one of the world's leading pharmaceutical companies, where he leverages his expertise to make advancements in drug development. His contributions have not only enriched his company’s research portfolio but also paved the way for future breakthroughs in cancer therapeutics.

Collaborations

Throughout his career, Miao has collaborated with accomplished professionals such as Feng He and Zhuoliang Chen. These collaborations emphasize a mutual dedication to advancing scientific knowledge and improving treatment options for serious health conditions.

Conclusion

Miao Dai's innovative spirit and dedication to cancer research illustrate the vital role inventors play in pushing the boundaries of science and medicine. His work not only contributes to the body of knowledge in medicinal chemistry but also offers hope to those affected by proliferative diseases. With his continued efforts at Novartis AG, Miao is set to remain at the forefront of pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…